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Abstract We have previously shown the differential
expression of versican in the mouse uterus under ovarian
hormone influence. We also demonstrated there is not a
direct correlation between mRNA levels and protein
expression, suggesting posttranscriptional events, such as
alteration in mRNA stability. This posttranscriptional effect
may result in the elongation and stabilization of transcripts
poly(A) tail. Thus, the aim of this study was to analyze
whether estradiol (E2) regulates versican mRNA stability
and expression in a dose-related and time-dependent man-
ner. For this purpose female mice were ovariectomized and
treated with a single injection of 0.1 or 10 lg E2. To block
transcription a group of females received a single injection of
alpha-amanitin before hormone administration. Uterine tis-
sues were collected 30 min, 1, 3, 6, 12 and 24 h after treat-
ments and processed for quantitative real time PCR (qPCR),
RACE-PAT Assay and immunohistochemistry. qPCR
showed that versican mRNA levels are higher than control
from 3 to 24 h after E2 administration, whereas after tran-
scription inhibition versican mRNA unexpectedly increases
within 3 h, which can be explained when transcriptional
blockers alter the degradation rate of the transcript, resulting
in the superinduction of this mRNA. Accordingly, analysis
of versican transcript poly(A) tail evidenced a longer product
3 h after treatment, but not after 12 h. Versican immunore-
action becomes conspicuous in the superficial stroma only
3 h after E2 injection, whereas the whole stroma is immu-
noreactive from 6 h onward. These results demonstrate that
E2 modulates versican at the transcriptional and posttran-
scriptional levels in a time-dependent manner.
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Introduction
The extracellular matrix (ECM) is a complex structure of
macromolecules capable of self-assembly and is composed
predominantly of collagens, non-collagenous multiadhesive
glycoproteins, elastin, hyaluronan and proteoglycans (Kresse
and Scho¨nherr 2001). The ECM of the uterine tissues plays
important functions in endometrial decidualization, embryo
implantation, trophoblast cell invasion and the maintenance of
gestation (Aplin et al. 1988; Iwahashi et al. 1996; Abrahamsohn
and Zorn 1993; Aplin 2002). Data from our group have dem-
onstrated that in mice, the deposition of collagens and proteo-
glycans in the uterine tissue varies along the estrous cycle and
during early pregnancy (San Martin et al. 2003; Spiess et al.
2007; Salgado et al. 2009a). In addition, using a model of
ovariectomy and hormone replacement as experimental strat-
egy, it was demonstrated that the expression and deposition of
proteoglycans, such as the small leucine-rich proteglicans
biglycan, decorin, fibromodulin and lumican, as well as versi-
can, are differentially modulated in the uterine tissues by estra-
diol (E2) and progesterone (P4) (Salgado et al. 2009b, 2011).
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Versican is a large chondroitin sulfate proteoglycan that
belongs to the family of hyaluronan-binding proteoglycans
termed hyalectins, and is found in many soft tissues. It
influences the formation of the ECM network and modulates
cell–matrix and cell–cell interactions, acting on cell prolif-
eration and differentiation (Shinomura et al. 1995; Zim-
mermann 2000; Wight 2002). A previous study (Salgado
et al. 2009b) has shown that the expression and distribution
of versican in the mouse uterus are region-specifically
modulated by ovarian hormones E2 and P4. This work also
demonstrated that there is not always a direct correlation
between mRNA levels and protein deposition, indicating
that posttranscriptional events, such as regulation of RNA
stability, may be involved in this modulation process.
The biological effects of E2 and P4 are mediated by
nuclear and membrane-associated receptors. At the nucleus,
these receptors act as transcription factors regulating gene
expression by direct binding to DNA regulatory sequences of
genes and by interactions with other transcription factors,
such as c-fos and c-jun, in a process modulated by co-regu-
lators (Lydon et al. 1995; Weihua et al. 2000).
Membrane-associated steroid receptors of rapid action
have been described, and their effects are mediated by
protein G-associated mechanisms (Song et al. 2005).
Alteration in mRNA stability may be induced by non-
genomic action of steroid hormones (Review in Ing 2005).
One of these posttranscriptional effects is the elongation of
mRNA poly(A) tail, making transcripts more stable and
efficiently translated, thus generating more protein. For
instance, the ECM glycoprotein fibulin-1 is differentially
modulated in an ovarian cancer cell line. The expression of
both splice variants, fibulin-1C and fibulin-1D, is influenced
by E2 at the transcriptional level. However, only fibulin-1D
mRNA is posttranscriptionally regulated, by reduction of its
half-life from 8 to 5.5 h (Bardin et al. 2005).
Several studies demonstrate that E2 regulates ECM
remodeling, through synthesis and cleavage of its compo-
nents by matrix metalloproteinases. On the other hand,
little is known about the complex relationship between E2,
regulation of mRNA stability and deposition of ECM
molecules in the uterine tissues. Therefore, the present
work aimed to unveil the effects of E2 on versican mRNA
levels and stability, and the deposition of the proteoglycan
in the uterine ECM of ovariectomized hormone-treated
mice, in a dose-related and time-dependent manner.
Materials and methods
Animals and tissue collection
Swiss female mice, aged 3–5 months, were used in this
study. Animals were housed in a 12-h light: 12-h dark,
temperature-controlled (22 C) environment, with free
access to food and water. For tissue collection, animals
were anesthetized with an intraperitoneal injection of tri-
bromoethanol (Avertin) (0,025 mL/g body weight). The
uteri were subsequently removed, cut with razor blades and
immediately immersed in a fixative solution or stored in
RNAlater solution (Sigma-Aldrich, St. Louis, MO, USA,
#077K1749). National guidelines for laboratory animal
care were followed, and all experiments were approved by
the Institute of Biomedical Sciences Animal Ethics Com-
mittee (authorization number, 144/2002).
Hormone replacement protocol
All females were ovariectomized (OVX), under Avertin
anesthesia, twenty days before treatments. Five experi-
mental groups were designed: 1) control mice (vehicle); 2)
mice treated with 0.1 lg E2; 3) mice treated with alpha-
amanitin from Amanita phalloides (A-amanitin) (Sigma-
Aldrich, #099K4041) and 0.1 lg E2; 4) mice treated with
10 lg E2; 5) mice treated with A-amanitin and 10 lg E2.
A-amanitin is a well known transcription blocker and
in vivo experiments using this reagent have been previ-
ously published (Lee and Ling 2003). Briefly, mice in
groups 2 and 4 received an i.p. A-amanitin injection
(diluted in distilled water, 50 lg/100 g body weight). After
1 h, the animals were treated with vehicle or the respective
dose of E2; 17b-estradiol (E2) (Sigma-Aldrich, #E8875)
was diluted in 50 % ethyl alcohol and injected via caudal
vein in a 50 ll volume.
All four treated groups, except the control group, were
each divided into six subgroups, in which the animals were
sacrificed after a specific period of time following hormone
administration: 30 min, 1, 3, 6, 12 and 24 h (n = 5 per group).
mRNA extraction and RT-PCR
Upon use, uterine samples, excised with sterilized razor
blades and stored in RNAlater solution at -20 C, were
transferred to sterile microfuge tubes containing ceramic
beads and 500 ll of Trizol reagent (Invitrogen, Calbard,
CA, USA, #15596018). Samples were homogenized and
total RNA extracted using the Precellys 24 homogenizer
(Bertin Technologies, Saint-Quentin-en-Yvelines, France),
following the manufacturer’s instructions. RNA quantity
and quality (A260/A280) were assessed with a NanoDrop
spectrophotometer (Thermo Fisher Scientific Inc., USA)
and 1.2 % agarose gel electrophoresis. All samples were
pre-treated with DNAse I for 15 min (Invitrogen, #18068-
015) to remove undesired genomic DNA contamination.
Reverse transcription (RT-PCR) to synthesize first-strand
cDNA was performed for 1 h at 42 C with AffinityScript
QPCR cDNA Synthesis kit (PCR buffer, random primers
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and reverse transcriptase) (Stratagene, Cedar Creek, TX,
USA, #600559) and 1 lg of total RNA, in a 20 ll reaction
volume. The cDNA was diluted 1:5 for use in real-time
qPCR and stored at -20 C.
Quantitative real-time PCR (qPCR)
Different reference genes were tested and GAPDH (Glyc-
eraldehyde 3-phosphate dehydrogenase) was chosen as
internal control for showing the most uniform expression
across groups in the qPCR amplification experiments,
according to the NormFinder algorithm (Andersen et al.
2004). Efficiency of each pair of primers was determined by
amplification reaction with serial dilutions of a control
sample (investigated range from 2.5 ng to 40 ng), which
display the slope and the value of a in y = ax ? b (Effi-
ciency = 10-1/a). The relative levels of mRNA of the tested
genes were estimated by fluorescence quantified with the
RotorGene 6000 Series (Corbett Research, Australia).
Reactions were performed in a total volume of 25 ll con-
taining sterile water, 20 ng of cDNA and 900 nM of forward
and reverse primers in a reaction buffer containing SYBR
Green PCR master mix (Stratagene, Cedar Creek, TX, USA,
#600548). The reaction conditions consisted of one step at
95 C for 10 min, followed by 40 cycles of two steps: 30 s at
95 C (denaturation) and 60 s at 60 C (annealing). The
melting curves obtained, which showed a single amplicon
and no primer dimers, were programmed as follows:
60–95 C with a heating rate of 0.1 C per second and a
continuous fluorescence measurement. All Cq (quantifica-
tion cycle) values of the target gene (Vcn) were normalized
to the expression of the reference gene (GAPDH) and the
results were expressed as fold-induction relative to the
expression of the calibrator sample (control vehicle), arbi-
trarily set to 1, using the comparative Ct method. Primers
were designed with NCBI’s primer designing tool to span an
exon–exon junction, in order to limit amplification only to
mRNA. Primer sequences used were: Versican Forward–
9532TCCTGATTGGCATTAGTGAAG9552 and Reverse—
9689CTGGTCTCCGCTGTATCC9672 (158 bp, #NM_00108
1249); GAPDH Forward—840TCTGAGGGCCCACTGA
AG857 and Reverse– 1060AGGGTTTCTTACTCCTTGGA
GG1039 (221 bp, #NM_008084.2).
Evaluation of versican mRNA poly(A) tail length
Versican transcript poly(A) tail length was examined by a
rapid amplification of cDNA ends-poly(A) test (RACE-
PAT) (Salle´s et al. 1999).
In brief, 200 ng of an oligo(dT) anchor (50-GCGAGCT
CCGCGGCCGCG-T12) were added to 1 lg of total RNA
in a sterile RNase-free microfuge tube. The samples were
denatured at 70 C for 5 min, transferred to 42 C and
reverse transcribed for 60 min, using the AffinityScript
QPCR cDNA Synthesis kit (Stratagene).
Three microliters of the RT reaction product were mixed
to a reaction buffer containing MgCl2 (25 mM), 10 mM of
each dNTP, 25 pmol of each primer (Versican, 50-GTAC-
TAGAGCACAGAAAATC and anchor, 50-GCGAGCTCC
GCGGCCGCG-T12), 1.25 units of platinum Taq DNA
polymerase (Invitrogen Life Technologies, #10966-030)
and 10x Taq DNA polymerase buffer. The PCR reaction
was performed for 40 cycles; each cycle consisted of 95 C
for 30 s (denaturation), 64 C for 1 min (annealing), and
72 C for 1 min (extension), followed by a single final
7-min elongation step at 72 C.
The PCR-amplified products were submitted to elec-
trophoresis in 2.5 % agarose gel containing ethidium bro-
mide. Amplicon sizes were estimated by densitometry and
compared with a 100-bp DNA ladder (Invitrogen Life
Technologies, #15628-019) using the ImageQuant TL
v2005 software (Amershan Biosciences, Buckinghamshire,
UK). The top of the smear indicated the longest amplified
fragment, which represents the poly(A) tail size plus 212
bases upstream, according to the versican primer used.
Light microscopy processing
Samples were fixed at 4 C for 3 h in Methacarn (absolute
methanol, chloroform and glacial acetic acid; 6:3:1), rinsed
with absolute ethanol, and embedded in Paraplast (Merck,
Oxford, St. Louis, MO, USA, #1.11609) at 60 C. Samples
were cut into 5 lm sections, adhered to glass slides using
0.1 % Poly-L-lysine (Sigma, St. Louis, MO, USA, #P8920),
then dried at 37 C and stored at room temperature.
Immunoperoxidase procedure
Immunostaining was performed according to a previously
established protocol (Salgado et al. 2009b). Sections were
deparaffinized, hydrated and treated with 3 % (v/v) H2O2
in PBS (30 min) to block endogenous peroxidase activity.
They were subsequently incubated with Chondroitinase
ABC from proteus vulgaris (Seikagaku, Tokyo, Japan,
#100330), diluted in 20 mM Tris–HCl buffer pH 6.0 (1 h at
37 C), prior to the incubation with the primary antibody,
in order to digest the glycosaminoglycan side chains and
expose the epitopes to the antibody. Nonspecific staining
was blocked by incubating the sections (1 h) with normal
goat serum, diluted 1:1 (v/v) in PBS—10 % BSA (w/v)
(room temperature). The primary antibody was a versican
polyclonal antibody produced in rabbit (Lifespan, Seattle,
Washington, USA, #LS-C25140). The antibody was dilu-
ted 1:50 in PBS—0.3 % (v/v) Tween 20 and incubated
overnight (4 C). The sections were then incubated with
peroxidase-conjugated secondary anti-rabbit IgG (1:200)
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(KPL, Gaithersburg, Maryland, USA, #04-15-06), diluted
in PBS (v/v) (1h30 min, at room temperature). The per-
oxidase reaction was visualized using 0.03 % (w/v) 3,30-
diaminobenzidine (DAB) (Sigma-Aldrich, #868272-85-9)
in PBS with 0.03 % (v/v) H2O2. The sections were coun-
terstained with Mayer’s haematoxilin. Negative control
reactions consisted of replacing the primary antibodies
with the respective non-immune serum at similar concen-
trations or by omitting the primary antibody step from the
protocol. Uterine cross sections in diestrus phase of the
estrous cycle were used as positive control.
A Nikon Eclipse E600 microscope was used for exam-
ining sections. Images were captured using a digital camera
(Cool SNAP-Procf color; Roper Scientific, Trenton, NJ,
USA) and Image Pro Plus software (Media Cybernetics,
Silver Spring, MD, USA).
Statistical analysis
Comparisons between two distinct groups (control vs trea-
ted) were analyzed by the Student t test. Multiple compar-
isons were performed by one-way analysis of variance
(ANOVA) followed by the Student–Newman–Keuls post-
test to determine significant differences among all groups,
using Prism 5.0 (GraphPad Software, San Diego, CA,
USA). All results were expressed as the mean ± standard
error of the mean (SEM). Values of p less than or equal to
0.05 were considered statistically significant.
Results
Effect of E2 on versican gene expression in a dose-
related and time-dependent manner
Versican mRNA expression showed significant increase
from 3 h after administration of 0.1 lg E2 (p \ 0.05)
onward, when compared to the control group, reaching its
peak 12 h after treatment (p \ 0.001). Although there was
a significant decrease in versican mRNA in the 24 h group,
when compared to 12 h group (p \ 0.001—12 vs 24 h),
the content in the 24 h group was higher than in the control
group (p \ 0.001) (Fig. 1a).
Similarly to that observed in the 0.1 lg E2 group, in the
group treated with 10 lg of E2, versican mRNA expression
was significantly augmented only from 3 h (p \ 0.001)
onward. However, after administration of the higher dose,
transcript content reached its peak within 3 h of treatment,
earlier than was observed in the lower E2 dose (12 h)
treated animals. Interestingly, 6 h after treatment versican
transcript content significantly decreased (p \ 0.001—3 vs
6 h), increasing again 12 h after E2 administration
(Fig. 1b).
Effect of A-amanitin on versican gene
transcription arrest
Pre-treatment with A-amanitin promoted significant increase of
versican mRNA 3 h after E2 administration (p \0.01),
strongly suggesting an increase in mRNAm stability. Other-
wise, 12 h after 0.1 lg E2 administration, there was a signifi-
cant decrease (p\0.05) in versican mRNA levels and 12 h
after 10 lg E2 injection versican transcript content remain
unchanged, when compared to the control group, indicating that
mRNA stability is no longer enhanced. Therefore, this decaying
curve showed that transcription blocking was effective (Fig. 2a,
b).
Effect of E2 on versican transcript poly(A) tail length
In order to confirm whether E2 induces posttranscriptional
modifications in versican transcript, its poly(A) tail length
was analyzed. It was verified that the length of versican
mRNA poly(A) tail was significantly increased 3 h after
administration of 0.1 lg E2 (p = 0.0147) or 10 lg E2
Fig. 1 Versican mRNA expression shows significant increase from
3 h onward after administration of a 0.1 lg E2, when compared to the
control group, reaching its peak 12 h after treatment; b 10 lg E2—
however, after administration of the higher dose, transcript content
reaches its peak within 3 h of treatment, earlier than observed in the
lower E2 dose (12 h). 6 h after treatment versican transcript content
significantly decreases (3 vs 6 h), increasing again 12 h after E2
administration. Multiple comparisons performed by one-way analysis
of variance (ANOVA) followed by the Student–Newman–Keuls post
hoc test. Values represent the mean ± SEM on five independent
tissue preparations. *p \ 0.05; **p \ 0.01; ***p \ 0.001
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(p = 0.026), when compared to the control group. No
significant alteration in versican transcript poly(A) tail was
observed 12 h after 0.1 lg E2 or 10 lg E2, as expected
from the qPCR results obtained after transcription arrest
(Fig. 3a, b).
Analysis of versican deposition and distribution
in the uterine tissues
Hormone treatment—0.1 lg E2
In the control group (vehicle) a faint immunoreaction was
restricted to the subepithelial region of the antimesometrial
stroma. Thirty minutes, 1 and 3 h after E2 injection,
immunoreaction was similar to the control group. From 6 h
onward there was a conspicuous immunoreaction in the
whole stroma and in the connective tissue between muscle
layers. The smooth muscle tissue of the myometrium
showed no immunoreaction. Figure 4a–i show the immu-
nohistochemistry reactions, including negative and positive
control.
Hormone treatment—10 lg E2
The administration of 10 lg E2 showed that the immuno-
reactivity to versican in the uterine tissues was also
apparent only 3 h after hormone administration. Similarly
to that observed after 0.1 lg E2 injection, the immunore-
action was present in the whole endometrial stroma in the 6
and 12 h groups, however weaker than that observed in the
0.1 lg E2 groups. In addition, in the 12 h group it appears
as a dot-like staining throughout the whole stroma and
myometrial layers. After 24 h of E2 injection, the immu-
nodeposition of versican recedes in the endometrial stroma
(Fig. 5a–i).
A-amanitin and hormone treatment—0.1 lg E2
In the control group (vehicle) treated with a-amanitin,
immunoreaction for versican was present only in the
superficial stroma (Fig. 4j). Interestingly, 3 h after treat-
ment a moderate immunoreaction was observed in the
whole endometrial stroma (Fig. 4k), whereas it was
restricted to the subepithelial region 12 h after treatment
(Fig. 4l).
A-amanitin and hormone treatment—10 lg E2
The immunoreaction in the control group (vehicle) treated
with a-amanitin is observed in Fig. 5j. After transcription
block, a strong immunoreaction was observed in the whole
endometrial stroma and connective tissue between muscle
layers in the 3 h group. However, differently than that
Fig. 2 a and b Pre-treatment with A-amanitin promotes significant
increase of versican mRNA 3 h after E2 administration, strongly
suggesting an increase in mRNAm stability. Otherwise, 12 h after
0.1 lg E2 administration there is a significant decrease in versican
mRNA levels (3 vs 12 h), and 12 h after 10 lg E2 injection versican
transcript content remains unchanged, when compared to the control
group, indicating that mRNA stability is no longer enhanced. The
decaying curve observed shows that transcription blocking was
effective. Multiple comparisons performed by one-way analysis of
variance (ANOVA) followed by the Student–Newman–Keuls post
hoc test. Values represent the mean ± SEM on five independent
tissue preparations. *p \ 0.05; **p \ 0.01
Fig. 3 Versican mRNA poly(A) tail length analyzed by rapid
amplification of cDNA ends for poly(A) test (RACE-PAT). Swiss
female mice were treated for 3 and 12 h with 0.1 lg E2 (a) or 10 lg
E2 (b). Upper panels: Smearing pattern of PCR products of C and E2-
treated mice, in ethidium bromide-stained 2.5 % agarose gel. The
100 bp DNA ladder (L) was the reference for the analysis of
poly(A) tail length in base pairs (bp). Lower panels: The maximal
sizes of the amplicons, corresponding to the top of the smear of
control (black bar), estradiol-treated mice (white bars) are shown in
base pairs (bp). Results are expressed as mean ± SEM of 2
independent experiments (n = 4). *P \ 0.05, **P \ 0.01 versus
Control (one-way analysis of variance with Student–Newman–Keuls
as post hoc test)
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observed in the lower dose group, immunoreaction was
faint in the uterine tissues in the 12 h group (Fig. 5k, l).
Discussion
Hormone actions on target cells involve complex molecu-
lar mechanisms, especially in the uterus, an organ charac-
terized by a remarkable remodeling, which occurs through
synthesis, deposition and degradation of ECM molecules
(Abrahamsohn and Zorn 1993).
An important variable in the context of hormone actions is
the regulation of mRNA stability (Schauer 1991; Rao et al.
1994; Ing 2005). A pioneer study demonstrated that prolactin
is capable of enhancing the expression of the casein gene in
mammary gland, through the increase of its mRNA half-life
and stability (Guyette et al. 1979). For instance, Saceda et al.
(1998) showed that P4 increases its receptor mRNA half-life
from 6 to 12 h in primary culture of endometrial fibroblasts.
The present results suggest that the increase in versican
mRNA beginning only 3 h after hormone treatment is due to
alteration in its half-life induced by E2. In accordance, an
in vivo study showed that exogenous estrogen administration
is able to up-regulate ER transcription, as well as its protein
concentration, in the uterus of ovariectomized ewe by sta-
bilizing ER mRNA (Ing et al. 1996).
The cytosolic compartment of the cells contains a pro-
tein system formed by RNAses and their inhibitors the
RNAsins, which control RNA turnover. It’s been reported
that this system is regulated by E2, influencing the degra-
dation/stabilization of cytoplasmic mRNAs (Rao et al.
1994). The decrease from 3 to 6 h after E2 administration
in versican mRNA level may be a time-controlled conse-
quence of transcript deadenilation (poly(A) tail shortening)
and degradation by RNAses, followed by de novo synthesis
in the endometrial stroma.
Fig. 4 a In the control group (vehicle) a faint immunoreaction is
observed in the subepithelial region of the antimesometrial stroma
(asterisk); b 30 min; c 1 h and d 3 h after E2 injection, immunore-
action is similar to the control group; e 6 h; f 12 h and g 24 h after
treatment there is a strong immunoreaction in the whole endometrial
stroma and in the connective tissue between muscle layers; h and
i show the positive and negative control, respectively. After
a-amanitin treatment, immunoreaction for versican is present only
in the superficial stroma in j control group. In k 3 h after treatment, a
moderate immunoreaction is observed in the whole endometrial
stroma; l In the 12 h group, the staining is restricted to the superficial
stroma. L uterine lumen, SS Superficial Stroma, DS Deep Stroma,
M Myometrium. Scale Bar = 200 lm
226 J Mol Hist (2013) 44:221–229
123
The decay of mRNAs is not a random process. It is
finely controlled and is triggered by three main events:
poly(A) tail shortening, premature arrest of translation and
exonucleolytic digestion, which are not necessarily exclu-
sive. Poly(A) tracts are gradually shortened in the cyto-
plasm in a mRNA-specific manner and this is normally a
rate-determining event that triggers turnover of the body of
the transcript (Jacobsen and Peltz 1996).
The posttranscriptional regulation mechanism reported
in the present work occurs at the transcript polyadenylation/
deadenylation level, leading to alteration in versican mRNA
poly(A) tail length, which is directly correlated to transcript
stability and translation efficiency (Bernstein et al. 1989;
Serrano-Nascimento et al. 2010). The addition of adenine
residues to the transcript’s 30-untranslated region protects it
from specific exoribonuclease and endonuclease attack, as
demonstrated 3 h after E2 treatment when a longer tran-
script poly(A) tail was observed.
Interestingly, our results from experiments in which
mice were treated with A-amanitin to block transcription
showed an unexpected increase in versican mRNA levels
3 h after treatment, a phenomenon known as superinduc-
tion of mRNAs, which may occur upon treatment with
transcriptional inhibitors. In fact, superinduction has been
previously observed by Lee and Ling (2003), whose work
proposes it could be due to the blockage of expression of
factors involved in mRNA degradation, induced by a spe-
cific treatment, leading to stabilization and accumulation of
mRNA pools in the cytoplasm.
The decaying curve on versican mRNA levels after
transcription blocking and the analysis of its poly(A) tail
length strengthen this hypothesis. Transcripts tend to be
Fig. 5 a In the control group (vehicle) a faint immunoreaction is
observed in the subepithelial region of the antimesometrial stroma
(asterisk); b 30 min and c 1 h after E2 injection, immunoreaction has
a similar pattern of deposition than control; d 3 h; e 6 h; f 12 h after
treatment the immunoreaction is present in the whole endometrial
stroma and in the connective tissue between muscle layers, however it
is weaker than in the previous dose; g In the 24 h group, the
immunodeposition recedes; h and i show the positive and negative
control, respectively. After a-amanitin treatment, immunoreaction for
versican is present only in the superficial stroma in j control group.
Interestingly, k 3 h after treatment a strong immunoreaction is
observed in the whole endometrial stroma; L) In the 12 h group, the
staining is faint from the uterine tissues. L uterine lumen, SS
Superficial Stroma, DS Deep Stroma, M Myometrium, G endometrial
gland. Scale Bar = 200 lm
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more stable with a longer poly(A) tail, thus 3 h after E2
injection versican mRNA content is posttranscriptionally
modulated, whereas 12 h after treatment there is a tran-
scriptional modulation of versican expression.
The immunohistochemical analysis of versican deposition
in the uterine ECM corroborates the molecular findings. In
the control group (vehicle) there is a weak reaction in the
subepithelial stroma. We infer that ovariectomy doesn’t
entirely suppress the stimulus on versican expression due to a
basal hormonal modulation from other sources, such as the
adrenal gland. It is worth mentioning that there is a clear
compartmentalization of the endometrial stroma into super-
ficial and deep regions, formed by genetically distinct cell
populations (Oliveira et al. 1998; Zorn et al. 2003). The dif-
ference in the immunodeposition pattern observed between
both doses is certainly due to a dose-dependent effect of E2 on
versican expression. Besides mRNA degradation and there-
fore translation arrest, one should also account for the action
of ADAMTS (A Disintegrin And Metalloproteinase with
ThromboSpondin motifs), classic proteoglycan cleavers, that
act as versicanases in extracellular matrices (Lee et al. 2005;
Stanton et al. 2011) and are indeed produced by uterine epi-
thelial and stromal cells under hormone regimen (unpub-
lished data, manuscript in preparation).
In conclusion, the present results demonstrate for the first
time that E2 modulates the ECM proteoglycan versican, at the
transcriptional and posttranscriptional levels by regulating the
rate of transcription, mRNA stability, and its protein deposi-
tion (and degradation) in the ECM in a dose-related and time-
dependent manner. It is likely that similar mechanisms act in
the remarkable and swift modulation observed in other ECM
molecules present in the uterine tissues.
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